Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
2.0%
1w
13.6%
1m
5.7%
3m
3.9%
6m
19.6%
1y
12.8%
5y
8.8%
all
20.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 28.6 2.0%
23.3
33.5
Company Overview

Sales
105 Cr
Growth: -11.4%
Profit after Tax
-19.5 Cr
Growth: -10.2%
Micro Cap
143 Cr
P/S: 1.4x
Industry P/S: 3.3x
Fundamentals

Sales (Cr) ₹ 105
Growth -11.4%
EBITDA -0.1%
P/S 1.4x
Dividend 0.0%
P/E -7.3x
Book Value ₹ 19
PEG Ratio 0.6x
ROE -18.6%
P/B 1.5x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (18)
Followers (3)